Analysts' average 12-month price target for National Health Investors is $80.
Get informed when a big investor buys or sells
+ Follow$66.92
6 analysts in the last 4 months
High: $81 | Low: $78
No recommendations in the last 4 months.
As of the most recent data, NHI shows a target price of $80. Scroll down for historical charts and peer comparison views.
If National Health Investors moved to the average analyst target of $80, shares would be roughly 19.0% higher than $66.92. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of National Health Investors's earnings trajectory.
Besides this target price page, Stockcircle has National Health Investors's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $80) with ownership activity and broader fundamentals.
National Health Investors's target price is $80; compare it with other Finance names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.